Liver transplant patients (LTx) have an increased risk for developing de novo malignancies,
but for colorectal cancer (CRC) this risk is less clear. We aimed to determine whether the …

The introduction of newer therapies for the treatment of multiple sclerosis has generated
considerable optimism. That optimism has been tempered by the potential risks of these …

Background Primary sclerosing cholangitis (PSC) confers an increased risk of colon cancer
in patients with inflammatory bowel disease (IBD). However, there is a scarcity of data to …

Objective Liver transplantation (LT) is the treatment of choice for end‐stage liver disease.
The required immunosuppression increases the risk for developing malignancies. Some …

Transcription factors (TFs) like a nuclear factor of activated T‐cells (NFAT) and its controller
calcineurin are highly expressed in primary intestinal epithelial cells (IECs) due to …

Liver transplantation has been the treatment of choice for end-stage liver disease since
1983. Cancer has emerged as a major long-term cause of death for liver transplant …

Introduction The incidence of colorectal cancer posttransplantation is unclear. Limited
reports exist and have conflicting conclusions. We aimed to review the clinical features and …

BACKGROUND: The epidemiology of colorectal neoplasm in liver transplantation recipients
has not been fully determined. OBJECTIVE: The aim of this study was to evaluate the …

Materials and Methods This was a retrospective, single-centered, case-control study. We
reviewed 348 liver transplant patients who had undergone a colonoscopy after liver …

Background Most of the current research in gastrointestinal oncology is focused on biology
of cancer itself, but there is growing interest in the patient's immune system response and its …